Barbara A. Goff, MD
Top Doctor
The Top Doctor award is a peer-nominated award for providers who give exceptional care.
Physician
Seattle Cancer Care Alliance
Seattle Cancer Care Alliance
Professor, Division of Gynecologic Oncology
University of Washington School of Medicine
University of Washington School of Medicine
Chair, Obstetrics and Gynecology
UW Medicine
UW Medicine
Affiliate Investigator
Fred Hutchinson Cancer Research Center
Fred Hutchinson Cancer Research Center
Clinical expertise
Gynecologic oncology
Gynecologic oncology
Located at
“
I believe in a comprehensive and compassionate multidisciplinary approach to treatment of gynecological malignancies.
”—
Dr. Goff
Clinical expertise
Gynecologic Oncology
Gynecologic Oncology
Medical Degree
University of Pennsylvania School of Medicine
University of Pennsylvania School of Medicine
Residency
Brigham and Women's Hospital, Obstetrics & Gynecology
Brigham and Women's Hospital, Obstetrics & Gynecology
Fellowship
Massachusetts General Hospital, Gynecology & Oncology
Massachusetts General Hospital, Gynecology & Oncology
Board Certification
Gynecologic Oncology, 1996; Obstetrics & Gynecology, 1994, American Board of Obstetrics & Gynecology
Gynecologic Oncology, 1996; Obstetrics & Gynecology, 1994, American Board of Obstetrics & Gynecology
Languages
English
Your care team
At SCCA, you receive care from a team of providers with extensive experience in your disease. Your team includes doctors, a team coordinator, a registered nurse, an advanced practice provider and others, based on your needs. You also have access to experts like nutritionists, social workers, acupuncturists, psychiatrists and more who specialize in supporting people with cancer or blood disorders.
Registered nurse (RN)
Your nurse manages your care alongside your physician and assists with care procedures and
treatments.
Team coordinator (TC)
Your team coordinator works closely with you and your physician and serves as your scheduler.
Clinical trials
We make promising new treatments available to you through studies called clinical trials led by SCCA doctors. Many of these trials at SCCA have led to FDA-approved treatments and have improved standards of care globally. Together, you and your doctor can decide if a study is right for you.
A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3) (DUET-3)
Study No:
NCT03752398
Phase:
Phase I
TR1801-ADC in Patients With Tumors That Express c-Met
Study No:
NCT03859752
Phase:
Phase I
A Phase 1, Study Evaluating the Safety, Tolerability, PK, and Efficacy of AMG 510 in Subjects With Solid Tumors With a Specific KRAS Mutation.
Study No:
NCT03600883
Phase:
Phase I
A Study of RO7198457 (Personalized Cancer Vaccine [PCV]) as a Single Agent and in Combination With Atezolizumab in Participants With Locally Advanced or Metastatic Tumors
Study No:
NCT03289962
Phase:
Phase I
Publications
Many of our SCCA physicians conduct ongoing research to improve standards of patient care. Their work is evaluated by other physicians and selected for publication to the United States National Library of Medicine, the largest medical library in the world. See scientific papers this SCCA provider has written.
Re-Engineering Academic Departments of Obstetrics and Gynecology to Operate in a Pandemic World and Beyond - A Joint AGOS/CUCOG Statement.